Obstructive jaundice after PTCD with infection: analysis of multiple factors

doi:10.3877/cma.j.issn.2095-5782.2022.03.015

Abstract

Abstract:

Obstructive jaundice is a common clinical hepatobiliary disease. If patients with related symptoms are not treated promptly and effectively, the massive accumulation of bile can rapidly cause liver and kidney failure, coagulation dysfunction, and even threaten patients' lives, in addition to manifesting yellow sclerae of the skin. Percutaneous transhepatic cholangial drainage (PTCD) is an effective means of relieving biliary obstruction and draining bile, but infection is a common complication after PTCD, which may affect the patient's prognosis and may cause perioperative death in severe cases. In this paper, we review the factors influencing postoperative infection in PTCD in pursuit of a better prevention and control of postoperative infection and improve the survival rate of patients.

Key words: PTCD, Obstructive jaundice, Infection, Antibiotics, Prognosis

Linyan Lou, Lizhou Wang, Shi Zhou, Tianpeng Jiang, Dongniang Lei, Xing Zheng. Obstructive jaundice after PTCD with infection: analysis of multiple factors[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(03): 306-311.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2022.03.015

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2022/V10/I03/306

References 49

[1]	Dorcaratto D, Hogan NM, Muñoz E, et al. Is percutaneous transhepatic biliary drainage better than endoscopic drainage in the management of jaundiced patients awaiting pancreaticoduo-denectomy? A systematic review and meta-analysis[J]. J Vasc Interv Radiol, 2018, 29(5): 676-687.
[2]	Cao JQ, Wang ZX, Cai HZ, et al. Effect of PTCD-based biliary stent placement combined with ¹²⁵I particle intracavitary irradiation in treating pancreatic head cancer[J]. J BUON, 2020, 25(2): 1056-1062.
[3]	Zhu JH, Wu W, Hu KW, et al. Percutaneous transhepatic cholangiography and drainage and endoscopic retrograde cholangiopancreatograph for hilar cholangiocarcinoma: which one is preferred?[J]. Rev Esp Enferm Dig, 2020, 112(12): 893-897.
[4]	Tang K, Sui LL, Xu G, et al. Effects of different palliative jaundice reducing methods on immunologic functions in patients with advanced malignant obstructive jaundice[J]. Anticancer Res, 2017, 37(8): 4665-4670.
[5]	Wu J, Song L, Zhang Y, et al. Efficacy of percutaneous transhepatic cholangiodrainage (PTCD) in patients with unresectable pancreatic cancer[J]. Tumor Biology, 2014, 35(3): 2753-2757.
[6]	谢兴武, 唐先志, 吴鹏, 等. 经皮肝穿刺胆道引流术后胆道感染的主要病原菌类型及药敏试验分析[J]. 中华介入放射学电子杂志, 2018, 6(4): 306-310.
[7]	咸蕾, 薛苏阳, 庄树武, 等. 胆道支架联合经皮肝穿刺胆管引流术治疗恶性梗阻性黄疸的临床疗效[J]. 中国老年学杂志, 2016, 36(17): 4250-4251.
[8]	Pedersoli F, Schröder A, Zimmermann M, et al. Percutaneous transhepatic biliary drainage (PTBD) in patients with dilated vs. nondilated bile ducts: technical considerations and complications[J]. European radiology, 2021, 31(5): 3035-3041.
[9]	Ahn S, Lee YS, Lim KS, et al. Malignant biliary obstructions: can we predict immediate postprocedural cholangitis after percutaneous biliary drainage?[J]. Support Care Cancer, 2013, 21(8): 2321-2326.
[10]	李阳, 张庆桥, 茅一萍, 等. 介入操作对不同疾病患者术后感染及相关因素分析[J]. 中华医院感染学杂志, 2018, 28(8): 1224-1228.
[11]	Ginat D, Saad WE, Davies MG, et al. Incidence of cholangitis and sepsis associated with percutaneous transhepatic biliary drain cholangiography and exchange: a comparison between liver transplant and native liver patients[J]. AJR, 2011, 196(1): W73-W77.
[12]	成丕光, 王建强, 石天亭, 等. 梗阻性黄疸患者经皮肝穿胆道引流术后胆道感染的分析[J]. 中华医院感染学杂志, 2016, 26(12): 2753-2755.
[13]	王炜, 刘会春, 庞青, 等. 经皮胆道双金属支架植入治疗恶性高位胆道梗阻的疗效[J]. 介入放射学杂志, 2019, 28(8):773-777.
[14]	Federico P, Anja S, Markus Z, et al. Percutaneous transhepatic biliary drainage (PTBD) in patients with dilated vs. nondilated bile ducts: technical considerations and complications[J]. European Radiology, 2021, 31: 3035-3041.
[15]	程龙, 靳勇, 白旭明, 等. 经皮经肝胆道引流术后胆道感染的相关因素分析[J]. 介入放射学杂志, 2012, 21(6): 509-513.
[16]	陈伟伟, 黄坤, 刘锐, 等. 经皮肝穿刺胆管引流术联合胆道支架植入术治疗高位恶性梗阻性黄疸的效果及预后影响因素分析[J]. 临床肝胆病杂志, 2019, 35(3): 559-564.
[17]	黄凯鹏, 李哲, 赵龙栓. 两种不同经皮肝穿刺胆道引流术的疗效观察[J]. 中华普通外科杂志, 2018, 33(5): 385-387
[18]	孙瑞杰, 林华鹏. 急性梗阻性化脓性胆管炎PTCD术后感染的病原菌分布及相关因素分析[J]. 中国病原生物学杂志, 2020. 15(7): 842-845.
[19]	贾一平, 茅爱武, 蒋霆辉, 等. 梗阻性黄疸经皮肝穿刺胆道引流感染发生因素的探讨[J]. 东南大学学报(医学版), 2015, 34(3): 352-356.
[20]	Xu C, Huang XE, Wang SX, et al. Comparison of infection between internal-external and external percutaneous transhepatic biliary drainage in treating patients with malignant obstructive jaundice[J]. Asian Pac J Cancer Prev, 2015, 16(6): 2543-2549.
[21]	刘锐, 黄坤, 陈伟伟, 等. 胆道支架治疗恶性梗阻性黄疸早期疗效及其影响因素[J]. 中国介入影像与治疗学, 2019, 16(5): 264-269.
[22]	de Jong EA, Moelker A, Leertouwer T, et al. Percutaneous transhepatic biliary drainage in patients with postsurgical bile leakage and nondilated intrahepatic bile ducts[J]. Dig Surg, 2013, 30(4-6): 444-450.
[23]	夏卿, 周新锋, 范晓翔, 等. 梗阻性黄疸患者经皮经肝胆道引流术后胆道感染相关因素研究[J]. 中华医院感染学杂志, 2017, 27(17): 3960-3963.
[24]	刘凌云, 鲁杰, 李香瑞. 经皮经肝胆道引流术后胆道感染的相关因素分析[J]. 中华医院感染学杂志, 2014, 24(24): 6165-6167.
[25]	Nennstiel S, Weber A, Frick Günter, et al. Drainage-related complications in percutaneous transhepatic biliary drainage: an analysis over 10 years[J]. J Clin Gastroenterol, 2015, 49(9): 764-770.
[26]	康庆民, 侯文静, 刘金龙, 等. 经皮穿肝胆管支架置入术治疗恶性梗阻黄疸发生早期胆道感染的风险及对策[J]. 中国现代医学杂志, 2016, 26(10): 84-88.
[27]	胡琦嵘, 王林俊, 丁孟德, 等. 梗阻性黄疸患者引流术后胆道感染的临床相关因素分析[J]. 中华医院感染学杂志, 2016, 26(10): 2296-2298.
[28]	黄继续, 陈蓉蓉, 翁溢鑫, 等. 介入治疗梗阻性黄疸患者胆道感染的影响因素分析[J]. 中华医院感染学杂志, 2019, 29(3): 415-417, 421.
[29]	朱飚, 傅建, 朱翔宇, 等. 恶性梗阻性黄疸患者PTCD术后胆道感染病原学与影响因素[J]. 中华医院感染学杂志, 2020, 30(23): 3644-3648.
[30]	Delden OMV, Laméris JS. Percutaneous drainage and stenting for palliation of malignant bile duct obstruction[J]. European Radiology, 2008, 18(3): 448-456.
[31]	Yu HP, Sun YY, Guo Z, et al. Multifactorial analysis of biliary infection after percutaneous transhepatic biliary drainage treatment of malignant biliary obstruction[J]. J Cancer Res Ther, 2018, 14(7): 1503-1508.
[32]	范小斌, 徐明洲, 贾亚鹏, 等. 恶性梗阻性黄疸PTCD术后胆道感染危险因素及sCD14-ST诊断价值[J]. 中华医院感染学杂志, 2021, 31(2): 233-237.
[33]	周欣, 姚高琼, 朱深银. 干预前后血管介入手术预防性应用抗菌药物的调查分析[J]. 重庆医学, 2015, 44(3): 369-371.
[34]	田甜, 李健健, 李艳, 等. 妇产科Ⅱ类切口围手术期预防应用抗生素的研究[J]. 中国妇产科临床杂志, 2017, 18(3): 261-262.
[35]	徐安辉, 漆剑频, 王南. 经皮腔内下肢血管成形术前预防性应用抗生素必要性研究[J]. 介入放射学杂志, 2015, 24(4): 297-300.
[36]	Turan AS, Jenniskens S, Martens JM, et al. Complications of percutaneous transhepatic cholangiography and biliary drainage, a multicenter observational study[J]. Abdom Radiol (NY), 2021. doi: 10.1007/s00261-021-03207-4.
[37]	黄光明. 介入治疗中抗生素的应用进展[J]. 中国介入影像与治疗学, 2016, 13(2): 122-125.
[38]	Heedman PA, Åstradsson E, Blomquist K, et al. Palliation of malignant biliary obstruction: adverse events are common after percutaneous transhepatic biliary drainage[J]. Scand J Surg, 2018, 107(1): 48-53.
[39]	Venkatanarasimha N, Damodharan K, Gogna A, et al. Diagnosis and management of complications from percutaneous biliary tract interventions[J]. Radiographics, 2017, 37(2): 665-680.
[40]	陈立军, 彭靖, 马军亮, 等. 急性结石性胆囊炎腹腔镜胆囊切除术预防性应用抗生素的疗效观察[J]. 中国普通外科杂志, 2019, 28(8): 1018-1022.
[41]	郭冬杰, 史录文, 张相林. 我院围术期预防使用抗菌药物改进情况分析[J]. 中国药学杂志, 2013, 48(7): 573-576.
[42]	Harsha M, Matthew B, Srinivas RP. Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review[J]. BioMed Central, 2016, 14(1): 182-193.
[43]	Saad WE. Percutaneous management of postoperative anastomotic biliary strictures[J]. Tech Vasc Interv Radiol, 2008, 11(2): 143-153.
[44]	Halpenny DF, Torreggiani WC. The infectious complications of interventional radiology based procedures in gastroenterology and hepatology[J]. J Gastrointestin Liver Dis, 2011, 20(1): 71-75.
[45]	Saad WE, Wallace MJ, Wojak JC, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy[J]. J Vasc Interv Radiol, 2010, 21(6): 789-795.
[46]	Brody LA, Brown KT, Getrajdman GI, et al. Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage[J]. J Vasc Interv Radiol, 1998, 9(4): 572-578.
[47]	Venkatesan AM, Locklin J, Dupuy DE, et al. Percutaneous ablation of adrenal tumors[J]. Tech Vasc Interv Radiol, 2010, 13(2): 89-99.
[48]	周建春, 赵孝杰, 彭启平, 等. 胆道手术患者胆汁培养及抗菌药物耐药性分析的临床研究[J]. 中华医院感染学杂志, 2011, 21(7): 1464-1467.
[49]	汪一帆, 艾芬. 胆道感染病原菌种类及药物敏感性分析[J].中国卫生检验杂志, 2012, 22(9): 2136-2138.

Please choose a citation manager

Content to export